Wearable Technology to Assess Gait Function in SMA and DMD

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Spinal Muscular Atrophy Type 3Duchenne Muscular Dystrophy
Interventions
OTHER

Observational

Observational

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Muscular Dystrophy Association

OTHER

collaborator

Stevens Institute of Technology

OTHER

lead

Columbia University

OTHER

NCT04193085 - Wearable Technology to Assess Gait Function in SMA and DMD | Biotech Hunter | Biotech Hunter